articleNew England Journal of MedicineApr 27, 2008BRONZE OA

Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

Children's Hospital of Philadelphia · Penn Presbyterian Medical Center · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477 [ClinicalTrials.gov]). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hRPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and…

Citation impact

2,131
total citations
FWCI
71.73
Percentile
100%
References
27
Citations per year

Authors

32

Topics & keywords

Keywords
  • Medicine
  • RPE65
  • Cis-trans-Isomerases
  • Retinal pigment epithelium
  • Visual acuity
  • Blinding
  • Adverse effect
  • Genetic enhancement
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.